NO20030222D0 - Stabile salter av O-acetylsalicylsyre med basiske aminosyrer - Google Patents

Stabile salter av O-acetylsalicylsyre med basiske aminosyrer

Info

Publication number
NO20030222D0
NO20030222D0 NO20030222A NO20030222A NO20030222D0 NO 20030222 D0 NO20030222 D0 NO 20030222D0 NO 20030222 A NO20030222 A NO 20030222A NO 20030222 A NO20030222 A NO 20030222A NO 20030222 D0 NO20030222 D0 NO 20030222D0
Authority
NO
Norway
Prior art keywords
amino acids
basic amino
acetylsalicylic acid
stable salts
salts
Prior art date
Application number
NO20030222A
Other languages
English (en)
Other versions
NO20030222L (no
Inventor
Gerhard Franckowiak
Hubert Appolt
Gregor Leifker
Hans-Peter Wirges
Wolfram Ledwoch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of NO20030222L publication Critical patent/NO20030222L/no
Publication of NO20030222D0 publication Critical patent/NO20030222D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine
NO20030222A 2000-07-18 2003-01-16 Stabile salter av O-acetylsalicylsyre med basiske aminosyrer NO20030222D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034802A DE10034802A1 (de) 2000-07-18 2000-07-18 Stabile Salze von O-Acetylsalicylsäure mit basischen Aminosäuren
PCT/EP2001/007669 WO2002005782A2 (de) 2000-07-18 2001-07-05 Stabile salze von o-acetylsalicylsäure mit basischen aminosäuren

Publications (2)

Publication Number Publication Date
NO20030222L NO20030222L (no) 2003-01-16
NO20030222D0 true NO20030222D0 (no) 2003-01-16

Family

ID=7649258

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20030222A NO20030222D0 (no) 2000-07-18 2003-01-16 Stabile salter av O-acetylsalicylsyre med basiske aminosyrer

Country Status (34)

Country Link
US (2) US6773724B2 (no)
EP (1) EP1365737B1 (no)
JP (2) JP2004507463A (no)
KR (1) KR100773658B1 (no)
CN (1) CN1205176C (no)
AR (1) AR030305A1 (no)
AT (1) ATE293589T1 (no)
AU (2) AU2001278471B2 (no)
BR (1) BR0112538A (no)
CA (1) CA2416288C (no)
CR (1) CR6888A (no)
CZ (1) CZ300337B6 (no)
DE (2) DE10034802A1 (no)
DK (1) DK1365737T3 (no)
EC (1) ECSP034437A (no)
ES (1) ES2241849T3 (no)
GT (1) GT200100134A (no)
HK (1) HK1061811A1 (no)
HR (1) HRP20030108B1 (no)
HU (1) HUP0302053A3 (no)
IL (2) IL153873A0 (no)
MX (1) MXPA03000510A (no)
MY (1) MY134521A (no)
NO (1) NO20030222D0 (no)
PE (1) PE20020267A1 (no)
PL (1) PL204593B1 (no)
PT (1) PT1365737E (no)
RS (1) RS50329B (no)
SK (1) SK286162B6 (no)
SV (1) SV2002000557A (no)
TW (1) TWI299729B (no)
UY (1) UY26841A1 (no)
WO (1) WO2002005782A2 (no)
ZA (1) ZA200300469B (no)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE10202019A1 (de) * 2002-01-18 2003-07-24 Bayer Ag Stabile Salze von o-Acetylsalicylsäure mit basischen Aminosäuren II
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
ES2330321T3 (es) * 2003-05-16 2009-12-09 Cephalon France Procedimiento de sintesis de modafinilo.
WO2006023844A2 (en) * 2004-08-20 2006-03-02 Entremed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (de) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stabiler Wirkstoffkomplex von Salzen der o-Acetylsalicylsäure mit basischen Aminosäuren und Glycin
DE102005049293A1 (de) * 2005-10-15 2007-04-26 Bayer Healthcare Ag Kombinationspräparate von Salzen oder o-Acetylsalicylsäure
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
JP5759672B2 (ja) 2006-07-09 2015-08-05 テックフィールズ バイオケム カンパニー リミテッド アスピリンの正荷電水溶性プロドラッグ
US20090238763A1 (en) * 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
KR20190091378A (ko) 2007-06-04 2019-08-05 테크필즈 인크 매우 높은 피부 및 막 침투율을 가지는 비스테로이드성 소염제(ｎｓａｉａ) 약물전구체 및 이들의 새로운 의약적 용도
DE102008004386A1 (de) * 2008-01-14 2009-07-23 Activaero Gmbh Verwendung eines Acetylsalicylsäuresalzes zur Behandlung viraler Infektionen
CN101314029B (zh) * 2008-06-18 2010-12-08 四川省农业科学院实验场 乙酰水杨酸肽及其制备方法
US20100120727A1 (en) * 2008-11-12 2010-05-13 Kyphia Pharmaceuticals, Inc. Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
CN113636965A (zh) 2008-12-04 2021-11-12 于崇曦 高穿透性组合物及其应用
BRPI1009600A2 (no) * 2009-06-25 2016-03-22 Tetra S A
CN101633624B (zh) * 2009-08-04 2013-05-01 蚌埠丰原医药科技发展有限公司 改进的赖氨匹林的制备方法
FR2965261B1 (fr) * 2009-09-30 2012-10-26 Holis Technologies Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
FR2950625B1 (fr) * 2009-09-30 2016-12-02 Holis Tech Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue
FR2973370B1 (fr) * 2011-03-29 2013-05-03 Holis Technologies Procede a faible cout pour la preparation d'un acide o-acetylsalicyclique et d'un acide amine basique
CN102503845A (zh) * 2011-09-28 2012-06-20 广州普星药业有限公司 一种dl-赖氨酸阿司匹林盐的制备方法及其应用
KR102443057B1 (ko) 2012-05-16 2022-09-14 테크필즈 파마 코., 엘티디. 폐 병태의 치료를 위한 고침투 전구약물 조성물 및 그의 약제학적 조성물
CN102976962B (zh) * 2012-11-20 2015-02-04 南京工业大学 L-鸟氨酸阿司匹林复盐及其制备方法和应用
FR3021654B1 (fr) * 2014-05-28 2016-06-24 Unither Pharmaceuticals Procede de preparation d'un sel d'acide acetylsalicylique et d'un acide amine basique
US10882811B2 (en) * 2016-12-23 2021-01-05 Aspiair Gmbh Synthesis of lysine acetylsalicylate glycine particles
CA3064012A1 (en) 2017-05-30 2018-12-06 Rhoshan Pharmaceuticals, Inc. In-vial deposition of a stable, sterile and crystalline o-acetyl salicylic acid (aspirin)
JPWO2019026992A1 (ja) * 2017-08-03 2020-06-18 参天製薬株式会社 クロルヘキシジンを含有する医薬組成物
CN113105326A (zh) * 2021-03-24 2021-07-13 海南卓华制药有限公司 赖氨匹林的制备方法及应用
CN114478287A (zh) * 2021-12-31 2022-05-13 蚌埠丰原医药科技发展有限公司 一种赖氨匹林晶型及制备方法和应用
WO2023131645A1 (en) 2022-01-05 2023-07-13 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
ES388158A1 (es) * 1971-02-11 1974-03-16 Liade Sa Lab Procedimiento de obtencion de sales solubles del acido ace-til salicilico.
JPS4856815A (no) * 1971-11-13 1973-08-09
JPS55127345A (en) * 1979-03-23 1980-10-02 Kyowa Hakko Kogyo Co Ltd Preparation of acetylsalicylic acid salt
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS56113741A (en) * 1980-02-13 1981-09-07 Mitsui Toatsu Chem Inc Preparation of crystal of acetylsalicylic acid salt
JPS5721345A (en) * 1980-07-15 1982-02-04 Mitsui Toatsu Chem Inc Purification of acetylsalicylate salt
CS247688B1 (cs) * 1984-12-22 1987-01-15 Evzen Kasafirek Způsob výroby soli lysinu s kyselinou acetylsalicylovou
JPS632929A (ja) * 1986-06-20 1988-01-07 Kao Corp アセチルサリチル酸製剤
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
DE4332093C2 (de) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermales therapeutisches System mit dem Wirkstoff Acetylsalicylsäure und Verfahren zu seiner Herstellung

Also Published As

Publication number Publication date
ECSP034437A (es) 2003-03-31
US6773724B2 (en) 2004-08-10
MY134521A (en) 2007-12-31
HUP0302053A2 (hu) 2003-09-29
US20050009791A1 (en) 2005-01-13
SV2002000557A (es) 2002-10-24
NO20030222L (no) 2003-01-16
US7449198B2 (en) 2008-11-11
AU2001278471B2 (en) 2004-07-22
HK1061811A1 (en) 2004-10-08
SK286162B6 (sk) 2008-04-07
US20020091108A1 (en) 2002-07-11
PL365648A1 (en) 2005-01-10
ATE293589T1 (de) 2005-05-15
BR0112538A (pt) 2003-09-09
JP2004507463A (ja) 2004-03-11
CZ2003164A3 (cs) 2003-04-16
DK1365737T3 (da) 2005-07-11
AU7847101A (en) 2002-01-30
EP1365737A2 (de) 2003-12-03
UY26841A1 (es) 2002-02-28
PE20020267A1 (es) 2002-06-08
KR100773658B1 (ko) 2007-11-05
DE50105985D1 (de) 2005-05-25
MXPA03000510A (es) 2004-04-20
DE10034802A1 (de) 2002-01-31
RS50329B (sr) 2009-09-08
GT200100134A (es) 2002-03-22
PT1365737E (pt) 2005-08-31
ZA200300469B (en) 2004-06-21
SK672003A3 (en) 2003-06-03
ES2241849T3 (es) 2005-11-01
YU2003A (sh) 2006-08-17
EP1365737B1 (de) 2005-04-20
JP2012131824A (ja) 2012-07-12
CZ300337B6 (cs) 2009-04-22
IL153873A (en) 2009-05-04
CA2416288A1 (en) 2003-01-15
IL153873A0 (en) 2003-07-31
PL204593B1 (pl) 2010-01-29
WO2002005782A2 (de) 2002-01-24
CN1468209A (zh) 2004-01-14
KR20030019586A (ko) 2003-03-06
WO2002005782A3 (de) 2003-10-02
HRP20030108B1 (en) 2006-12-31
AR030305A1 (es) 2003-08-20
CR6888A (es) 2004-10-28
CN1205176C (zh) 2005-06-08
HRP20030108A2 (en) 2005-02-28
HUP0302053A3 (en) 2010-03-29
CA2416288C (en) 2009-12-22
TWI299729B (en) 2008-08-11

Similar Documents

Publication Publication Date Title
NO20030222D0 (no) Stabile salter av O-acetylsalicylsyre med basiske aminosyrer
AU2001278471A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
HK1080371A1 (en) Stable salts of o-acetylsalicylic acid containing basic amino acids ii
ATE334190T1 (de) Verfahren zur l-aminosäureproduktion mit escherichia
ATE470711T1 (de) Verfahren zur l-aminosäureproduktion mit escherichia
IL187772A0 (en) Stabile active ingredient complex of salts of the o-acetylsalicylic acid with basic amino acids and glycine
IS8231A (is) Lyfjafræðilega gagnleg sölt karboxýlsýruafleiða
AU6605601A (en) Beta-amino acid nitrile derivatives
DK1328499T3 (da) Fremgangsmåde til fremstilling af carboxylsyresalte
PT1432685E (pt) Hidratos cristalinos de derivados de anilida do acido nicotinico e de benzoilanilida
GB0024693D0 (en) Beta-amino acid cyclic carboxylic acids
NO20015042D0 (no) Fremgangsmåter for fremstilling av optisk aktive aminosyrederivater
HUP0402292A3 (en) Production of ammonium salts of aromatic carboxylic acids
ITMI20031326A0 (it) Sali di acidi idrossicinnamici e di idrossistilbeni otticamente attivi
FR2843590B1 (fr) Derives de l'acide r(+)-2-amino-3-hydroxypropanoique a action glycinergique
FI20021510A (fi) Karboksyylihapon suolojen valmistusprosessi
EE04960B1 (et) Meetod arliminometlkarbamiinhappeestrite valmistamiseks
AR028272A1 (es) Inhibidores de la metaloproteasas de acido difluorobutirico
PL346386A1 (en) Method of obtaining novel derivatives of benzoic acid

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application